BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24349364)

  • 1. Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
    Wang SS; Liu YF; Ou YC; Chen CS; Li JR; Yang SF
    PLoS One; 2013; 8(12):e82804. PubMed ID: 24349364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of CA9 gene polymorphisms and environmental factors on oral-cancer susceptibility and clinicopathologic characteristics in Taiwan.
    Chien MH; Yang JS; Chu YH; Lin CH; Wei LH; Yang SF; Lin CW
    PLoS One; 2012; 7(12):e51051. PubMed ID: 23226559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms and haplotypes of carbonic anhydrase 9 can predict invasive squamous cell carcinoma of uterine cervix.
    Shen HP; Hsiao YH; Yang SF; Liu YF; Ko JL; Wang PH
    Int J Med Sci; 2018; 15(6):587-594. PubMed ID: 29725249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
    Wang SS; Hsieh MJ; Ou YC; Chen CS; Li JR; Hsiao PC; Yang SF
    Tumour Biol; 2014 Aug; 35(8):7483-90. PubMed ID: 24789429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survival.
    Hung SC; Wang SS; Li JR; Chen CS; Lin CY; Chang LW; Chiu KY; Cheng CL; Ou YC; Yang SF
    Urol Oncol; 2019 Sep; 37(9):573.e9-573.e17. PubMed ID: 30824390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features.
    Yu YL; Su KJ; Hsieh MJ; Wang SS; Wang PH; Weng WC; Yang SF
    PLoS One; 2014; 9(4):e93635. PubMed ID: 24691023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy.
    Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF
    Urol Oncol; 2019 Nov; 37(11):814.e9-814.e16. PubMed ID: 31155437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma.
    Hua KT; Liu YF; Hsu CL; Cheng TY; Yang CY; Chang JS; Lee WJ; Hsiao M; Juan HF; Chien MH; Yang SF
    Sci Rep; 2017 Jun; 7(1):4466. PubMed ID: 28667334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis.
    de Martino M; Klatte T; Seligson DB; LaRochelle J; Shuch B; Caliliw R; Li Z; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    J Urol; 2009 Aug; 182(2):728-34. PubMed ID: 19539328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
    Tung MC; Wen YC; Wang SS; Lin YW; Liu YC; Yang SF; Chien MH
    Int J Med Sci; 2018; 15(11):1187-1193. PubMed ID: 30123056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan.
    Tung MC; Hsieh MJ; Wang SS; Yang SF; Chen SS; Wang SW; Lee LM; Lee WJ; Chien MH
    PLoS One; 2014; 9(3):e91147. PubMed ID: 24608123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
    Li CC; Hsieh MJ; Wang SS; Hung SC; Lin CY; Kuo CW; Yang SF; Chou YE
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma.
    Lin YW; Wang SS; Wen YC; Tung MC; Lee LM; Yang SF; Chien MH
    Int J Med Sci; 2017; 14(11):1130-1135. PubMed ID: 29104467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of
    Hung SC; Wang SS; Li JR; Chen CS; Yang CK; Chiu KY; Cheng CL; Ou YC; Ho HC; Yang SF
    Int J Med Sci; 2018; 15(14):1731-1736. PubMed ID: 30588197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic instability persists in non-neoplastic urothelial cells from patients with a history of urothelial cell carcinoma.
    de Castro Marcondes JP; de Oliveira ML; Gontijo AM; de Camargo JL; Salvadori DM
    PLoS One; 2014; 9(1):e86162. PubMed ID: 24465937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions.
    Xu C; Yang X; Wang Y; Ding N; Han R; Sun Y; Wang Y
    Cancer Gene Ther; 2017 Jul; 24(7):297-303. PubMed ID: 28524154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
    Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J
    Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma.
    Lee HL; Chiou HL; Wang SS; Hung SC; Chou MC; Yang SF; Hsieh MJ; Chou YE
    Urol Oncol; 2018 Apr; 36(4):160.e15-160.e21. PubMed ID: 29277583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma.
    Tanaka N; Kato H; Inose T; Kimura H; Faried A; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Fukuchi M; Kuwano H
    Br J Cancer; 2008 Nov; 99(9):1468-75. PubMed ID: 18841153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.